Preserving the promise : improving the culture of biotech investment

Innovation meets the translation gap. Stop the madness and cure something -- Into the Valley of Death -- Clinical promise investment practice -- Velcade, a biotech success story -- biotechnology and the future of pharma -- Why pharma should care about the Valley of Death -- Porter's five forces and the market for angel capital -- Out of the frying pan : the fire's not so great either -- Getting to Australia -- Universities don't make what companies need. When is an experiment ready for the Valley of Death? -- Unintended consequences of applying for a patent -- What if it doesn't actually work? -- Building a better mousetrap -- Good innovation is not always a good investment. Due diligence and angel incentives -- What is value? -- Angels at the crux of invention -- Investment : a nuanced decision -- Ready for a long-term relationship with a science experiment? -- Investing in hockey sticks -- Harps for angels -- Connecting innovation to investment -- Technology transfer wastes money and innovation. Mitigating supplier power -- Preventing speeding by closing the road -- Breaking old habits